The Testing Center will no longer proctor exams for online courses due to capacity issues, leaving questions around what ...

PRINCETON, N.J., Jan. 6, 2026 /PRNewswire/ -- ETS's Praxis program, the leading provider of teacher licensure assessments, welcomes the adoption of Praxis as an approved licensure option in the state ...

BOSTON, Dec. 29, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...

Praxis Precision Medicines, Inc. (PRAX) stock is soaring in trading today, up 35% at time of writing, with shares reaching a value of $260, their highest value since the beginning of 2022. Current ...

Having already claimed a win for the phase 2 study of its seizure drug, Praxis Precision Medicines is hoping fresh efficacy data will form the backbone of an approval application for the sodium ...

Praxis Precision Medicines Inc. (NASDAQ: PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here. PRAX closed Thursday's regular ...

President Trump's comments about restarting weapons tests are not likely to lead to mushroom-cloud explosions over the New Mexico desert or seismic shaking underground in Nevada, according to the ...

GYEONGJU, South Korea — President Donald Trump said Wednesday he had instructed the Defense Department to “immediately” start testing nuclear weapons "on an equal basis" with other nations. “Because ...

The president's announcement that the U.S. would resume tests leaves questions. President Donald Trump raised questions Wednesday night about a decades-old U.S. prohibition on testing its nuclear ...

The Praxis® tests are a series of exams required by the Kentucky Education Professional Standards Board for individuals entering an educator preparation program and seeking certification to teach.

Seven months ago, independent clinical trial observers peeked at interim data for Praxis Precision Medicines’ essential tremor drug and recommended stopping the Phase 3 studies. Praxis kept going. On ...

Jeff Smith was dumbfounded when he received a colon cancer screening kit in the mail. The 68-year-old Minnesota man hadn't asked for the Cologuard test, and his doctor hadn't mentioned anything about ...